NS · Healthcare

Remus Pharmaceuticals Ltd (REMUS)

Pharmaceuticals & Biotechnology

Remus Pharmaceuticals Ltd (REMUS) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $9.40B, P/E ratio is 32.43, dividend yield is 0.06%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for REMUS

Market cap

$9.40B

P/E ratio

32.43

Dividend yield

0.06%

Remus Pharmaceuticals Ltd (REMUS) — FAQ

What is Remus Pharmaceuticals Ltd's market cap?

Remus Pharmaceuticals Ltd (REMUS) has a reported market cap of $9.40B (data as of 2026-07-10).

What is REMUS's P/E ratio?

The price-to-earnings (P/E) ratio for Remus Pharmaceuticals Ltd (REMUS) is 32.43 (data as of 2026-07-10).

Does Remus Pharmaceuticals Ltd pay a dividend?

Remus Pharmaceuticals Ltd (REMUS) shows a reported dividend yield of 0.06%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).

What sector is Remus Pharmaceuticals Ltd in?

Remus Pharmaceuticals Ltd (REMUS) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).

What exchange is REMUS listed on?

REMUS is listed on NS.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

09R (09R) 10X GENOMICS DL -00001 (1KJ) 160 Health International Ltd (2656) 1CM INC. (IQ70) 2cureX AB (2CUREX) 3-D Matrix Ltd (DMTRF) 3D Global Biotech Inc. (6808) 3D Medicines Inc (1244)